Ira Pastor, host of Progress, Potential and Possibilities, interviews Robert Geho

Latest Updates

News

Diasome’s HDV-Insulin for T1D Finalizing Phase III Plans After Promising Data

Diasome Pharmaceuticals to Present HDV-Insulin Phase 2b Clinical Data at EASD 2026 and Inaugural Breakthrough T1D Clinical & Research Congress

Diasome Pharmaceuticals Strengthens Leadership Team as Company Prepares for Phase 3 Development

WKYC: "A smarter insulin, better meal timing and the avocado test"